Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) US Launch and Outlines Strategic Priorities for 2019 - PRNewswire

Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) US Launch and Outlines Strategic Priorities for 2019  PRNewswire

-More Than 500 Patients Have Initiated Treatment and Approximately 600 Physicians Have Prescribed ARIKAYCE-. -Company to Present at 37th Annual J.P. ...



Comments

Popular posts from this blog

4 Symptoms of Stress You Should Never Ignore - AARP

Dyspnea (Shortness of Breath): Causes, Symptoms & Treatment - my.clevelandclinic.org

Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations - Healio